<code id='83A59EA9F7'></code><style id='83A59EA9F7'></style>
    • <acronym id='83A59EA9F7'></acronym>
      <center id='83A59EA9F7'><center id='83A59EA9F7'><tfoot id='83A59EA9F7'></tfoot></center><abbr id='83A59EA9F7'><dir id='83A59EA9F7'><tfoot id='83A59EA9F7'></tfoot><noframes id='83A59EA9F7'>

    • <optgroup id='83A59EA9F7'><strike id='83A59EA9F7'><sup id='83A59EA9F7'></sup></strike><code id='83A59EA9F7'></code></optgroup>
        1. <b id='83A59EA9F7'><label id='83A59EA9F7'><select id='83A59EA9F7'><dt id='83A59EA9F7'><span id='83A59EA9F7'></span></dt></select></label></b><u id='83A59EA9F7'></u>
          <i id='83A59EA9F7'><strike id='83A59EA9F7'><tt id='83A59EA9F7'><pre id='83A59EA9F7'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:16954
          James Comer -- coverage from STAT
          Rep. James Comer, chair of the House Oversight Committee Kevin Dietsch/Getty Images

          WASHINGTON — Congress wants to reform PBM business practices to help lower the cost of medicines — but don’t think they’ve forgotten drugmakers have a role in high drug prices.

          Two lawmakers, including a Republican, questioned PhRMA Chief Operating Officer Lori Reilly about just how much her group was spending on its major campaigns against PBMs this year. Both Reps. Summer Lee (D-Pa.) and Eric Burlison (R-Mo.) used their time to question drugmakers over their spending on lawsuits against Medicare drug price negotiation and ad campaigns against pharmacy benefit managers.

          advertisement

          Although Lee started off bashing PBMs for the fees they charge drugmakers, she quickly aimed her fire back on pharma. She said brand drugmakers charge Americans double what they charge other countries, and she asked why several drugmakers are suing the federal government over Medicare’s drug price negotiation.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Celiac disease study examines precisely how gluten triggers injury
          Celiac disease study examines precisely how gluten triggers injury

          AmicrographofCeliacdiseaseNephron/WikimediaCommonsForapersonwithceliacdisease,eatingabagelgoessometh

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          FDA panel gives mixed vote on blood pressure devices

          AdobeAnadvisorypaneltotheFoodandDrugAdministrationdeliveredasplitdecisiononasurgicalsystemusedinacon